6-[4-[3-(5-fluoro-4-oxo-2,3,4a,5,6,7,8,8a-octahydro-1H-quinazolin-2-yl)propanoyl]piperazin-1-yl]pyridine-3-carbonitrile

C21H27FN6O2 — CID 162370436

IUPAC6-[4-[3-(5-fluoro-4-oxo-2,3,4a,5,6,7,8,8a-octahydro-1H-quinazolin-2-yl)propanoyl]piperazin-1-yl]pyridine-3-carbonitrile
SMILESN#Cc1ccc(N2CCN(C(=O)CCC3NC(=O)C4C(F)CCCC4N3)CC2)nc1
InChIInChI=1S/C21H27FN6O2/c22-15-2-1-3-16-20(15)21(30)26-17(25-16)5-7-19(29)28-10-8-27(9-11-28)18-6-4-14(12-23)13-24-18/h4,6,13,15-17,20,25H,1-3,5,7-11H2,(H,26,30)
InChIKeyPYFHTUVSHYQCHO-UHFFFAOYSA-N
MW414.49 g/mol
LogP0.93
Rot. Bonds4

About 6-[4-[3-(5-fluoro-4-oxo-2,3,4a,5,6,7,8,8a-octahydro-1H-quinazolin-2-yl)propanoyl]piperazin-1-yl]pyridine-3-carbonitrile

6-[4-[3-(5-fluoro-4-oxo-2,3,4a,5,6,7,8,8a-octahydro-1H-quinazolin-2-yl)propanoyl]piperazin-1-yl]pyridine-3-carbonitrile (PubChem CID 162370436) has the molecular formula C21H27FN6O2 and a molecular weight of 414.49 g/mol. Its IUPAC name is 6-[4-[3-(5-fluoro-4-oxo-2,3,4a,5,6,7,8,8a-octahydro-1H-quinazolin-2-yl)propanoyl]piperazin-1-yl]pyridine-3-carbonitrile.

Molecular Properties

Compound Name6-[4-[3-(5-fluoro-4-oxo-2,3,4a,5,6,7,8,8a-octahydro-1H-quinazolin-2-yl)propanoyl]piperazin-1-yl]pyridine-3-carbonitrile
PubChem CID162370436
Molecular FormulaC21H27FN6O2
Molecular Weight414.49 g/mol
Exact Mass414.22
IUPAC Name6-[4-[3-(5-fluoro-4-oxo-2,3,4a,5,6,7,8,8a-octahydro-1H-quinazolin-2-yl)propanoyl]piperazin-1-yl]pyridine-3-carbonitrile
SMILESN#Cc1ccc(N2CCN(C(=O)CCC3NC(=O)C4C(F)CCCC4N3)CC2)nc1
InChIInChI=1S/C21H27FN6O2/c22-15-2-1-3-16-20(15)21(30)26-17(25-16)5-7-19(29)28-10-8-27(9-11-28)18-6-4-14(12-23)13-24-18/h4,6,13,15-17,20,25H,1-3,5,7-11H2,(H,26,30)
InChIKeyPYFHTUVSHYQCHO-UHFFFAOYSA-N
XLogP0.93
TPSA101.36 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds4
Heavy Atoms30
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500414.49
LogP ≤ 50.93
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Analyze 6-[4-[3-(5-fluoro-4-oxo-2,3,4a,5,6,7,8,8a-octahydro-1H-quinazolin-2-yl)propanoyl]piperazin-1-yl]pyridine-3-carbonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 6-[4-[3-(5-fluoro-4-oxo-2,3,4a,5,6,7,8,8a-octahydro-1H-quinazolin-2-yl)propanoyl]piperazin-1-yl]pyridine-3-carbonitrile?
The IUPAC name of 6-[4-[3-(5-fluoro-4-oxo-2,3,4a,5,6,7,8,8a-octahydro-1H-quinazolin-2-yl)propanoyl]piperazin-1-yl]pyridine-3-carbonitrile (CID 162370436) is 6-[4-[3-(5-fluoro-4-oxo-2,3,4a,5,6,7,8,8a-octahydro-1H-quinazolin-2-yl)propanoyl]piperazin-1-yl]pyridine-3-carbonitrile.
What is the SMILES notation for 6-[4-[3-(5-fluoro-4-oxo-2,3,4a,5,6,7,8,8a-octahydro-1H-quinazolin-2-yl)propanoyl]piperazin-1-yl]pyridine-3-carbonitrile?
The canonical SMILES for 6-[4-[3-(5-fluoro-4-oxo-2,3,4a,5,6,7,8,8a-octahydro-1H-quinazolin-2-yl)propanoyl]piperazin-1-yl]pyridine-3-carbonitrile is N#Cc1ccc(N2CCN(C(=O)CCC3NC(=O)C4C(F)CCCC4N3)CC2)nc1.
What is the InChIKey of 6-[4-[3-(5-fluoro-4-oxo-2,3,4a,5,6,7,8,8a-octahydro-1H-quinazolin-2-yl)propanoyl]piperazin-1-yl]pyridine-3-carbonitrile?
The InChIKey is PYFHTUVSHYQCHO-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H27FN6O2/c22-15-2-1-3-16-20(15)21(30)26-17(25-16)5-7-19(29)28-10-8-27(9-11-28)18-6-4-14(12-23)13-24-18/h4,6,13,15-17,20,25H,1-3,5,7-11H2,(H,26,30).
What are the key properties of 6-[4-[3-(5-fluoro-4-oxo-2,3,4a,5,6,7,8,8a-octahydro-1H-quinazolin-2-yl)propanoyl]piperazin-1-yl]pyridine-3-carbonitrile?
6-[4-[3-(5-fluoro-4-oxo-2,3,4a,5,6,7,8,8a-octahydro-1H-quinazolin-2-yl)propanoyl]piperazin-1-yl]pyridine-3-carbonitrile has a molecular weight of 414.49 g/mol, XLogP of 0.93, 4 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 6-[4-[3-(5-fluoro-4-oxo-2,3,4a,5,6,7,8,8a-octahydro-1H-quinazolin-2-yl)propanoyl]piperazin-1-yl]pyridine-3-carbonitrile is sourced from PubChem (CID 162370436), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).